MoneyWorks4Me

Sharon Bio-Medicine - Quaterly Results

07 Feb 2022 Evaluate
The revenue declined to Rs. 443.53 millions for the quarter ended December 2021 as compared to Rs. 452.35 millions during the corresponding quarter last year.The Company's Net profit for the December 2021 quarter have declined marginally to Rs. 40.22  millions as against Rs. 45.63 millions reported during the corresponding quarter ended.A decline of 69.02 millions was observed in the OP in the quarter ended December 2021 from 75.25 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 443.53 452.35 -1.95 1386.19 1242.92 11.53 1728.62 1712.16 0.96
Other Income 5.57 10.12 -44.96 16.85 20.28 -16.91 41.05 17.85 129.97
PBIDT 69.02 75.25 -8.28 215.07 171.98 25.06 257.34 281.96 -8.73
Interest 0.26 0.48 -45.83 0.87 1.36 -36.03 1.75 2.31 -24.24
PBDT 68.76 74.77 -8.04 214.20 170.62 25.54 255.59 -454.08 -156.29
Depreciation 28.54 29.14 -2.06 84.25 86.27 -2.34 115.12 110.59 4.10
PBT 40.22 45.63 -11.86 129.95 84.35 54.06 140.47 -564.67 -124.88
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 40.22 45.63 -11.86 129.95 84.35 54.06 140.47 -564.67 -124.88
Equity 11.51 11.51 0.00 11.51 237.87 -95.16 11.51 237.87 -95.16
PBIDTM(%) 15.56 16.64 -6.45 15.52 13.84 12.13 14.89 16.47 -9.60
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..